News
- LAVA study for COVID-19 begins in UK
- New WHO/Europe factsheet: policy action needed to reduce cancers attributable to alcohol use
- A life-sciences company conducts a clinical trial of regenerative medicine for COVID-19 and flu-elicited ARDS using Longeveron Mesenchymal Stem Cells
- King's College London started a new clinical trial of Lung Cancer detection using blood exosomes and HRCT
- Hopeful, colourful, simple: WHO adapts COVID-19 messages in Ukraine to the local audience
- EMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain, S.L.
- University Hospital Inselspital compares clinical outcome after Echocardiography-guided LAA-closure
- Private teaching hospital is studying the Vitamin D deficiency and COVID-19 disease severity
- Dutch biotechnology company conducts clinical trial of the Evoke Closed-Loop SCS System to treat patients with chronic pain of the Trunk and/or Limbs
- The research-led medical university is conducting study on Active Surveillance of Prostate Cancer
- The clinical trial of novel 3D Cartography-based targeted microwave focal therapy Device in men with risk Prostate Cancer started in Italy
- Medical University is studying prevalence and risk factors of SARS-CoV-2 in the Upper Silesian Agglomeration
- American internet company gets permission to start a clinical trial of an evaluation of a neurostimulation device for Insomnia
- Private research universitystarted a clinical trial of early intervention for young children at-risk for ADHD
- Czech University starts a clinical trial of early detection of Lung Cancer in high-risk asymptomatic individuals
- Swiss University Hospital is undertaking a phase Ib study of the combination of personalized Autologous Dendritic Cell Vaccine for Resected Pancreatic Adenocarcinoma
- Biopharmaceutical company conducts clinical trial for a procedure for Duodenal-Ileal Diversion with a Sleeve Gastrectomy for patients with obesity and type 2 Diabetes Mellitus
- Chinese company started a clinical trial of CAR-T Cell in the treatment of adult relapsed refractory acute Lymphoblastic Leukemia
- Ulipristal acetate for uterine fibroids: EMA recommends restricting use
- PAHO calls for improving diabetes control to prevent complications and severe COVID-19
- EMA publishes safety monitoring plan and guidance on risk management planning for COVID-19 vaccines
- Outstanding public health achievements from the WHO European Region receive the highest recognition at the resumed 73rd World Health Assembly
- More than 900 health professionals begin the course on the implementation and strengthening of Programs for Optimizing Antimicrobials in the Americas
- WHO/Europe is focusing on eye screening for people with diabetes
- First ever vaccine listed under WHO emergency use
Clinical Research News
Aankomende klinische onderzoeken
-
Aperta Biosciences, LLCNog niet aan het werven
-
Hospices Civils de LyonNog niet aan het wervenUrine-incontinentie | Neurogene blaas | Urinaire afleiding | Bekken maligniteit | UrineblaascarcinoomFrankrijk
-
Second Affiliated Hospital, Zhejiang University...WervingNormaal gehoor | Lawaai blootstelling | Preferred Loudness LevelChina
-
Qilu Pharmaceutical Co., Ltd.Nog niet aan het wervenHeldercellig niercelcarcinoom | Eierstokkanker | Andere gevorderde solide tumorenChina
-
University Hospital, AntwerpNog niet aan het wervenNecrotiserende enterocolitis bij pasgeborenen | Neonatale sepsis met late aanvangBelgië, Nederland
-
VA Office of Research and DevelopmentNog niet aan het wervenGemetastaseerde niet-kleincellige longkanker | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersVerenigde Staten
-
ENTire Medical Ltd.Nog niet aan het wervenHypertrofie | Tonsillectomie | Luchtwegobstructie Boven | Adenoïdectomie ChirurgieVerenigde Staten
-
AbbVieNog niet aan het wervenMatige tot ernstige psoriasis
-
Institute of Hematology & Blood Diseases Hospital...WervingAplastische anemie | Klonale hematopoëse | Immunosuppressieve therapieChina
-
Ahmed Nasser Ali MabkhoutWervingKaak cysten | Alveolar Bone DefectsJemen
-
University of CoimbraNog niet aan het werven
-
AbbVieNog niet aan het werven